Skip to main content
Carlo Contoreggi, MD, Nuclear Medicine, Baltimore, MD

CarloSalvatoreContoreggiMD

Nuclear Medicine Baltimore, MD

Chief, Nuclear and Molecular Imaging and Therapeutics

Dr. Contoreggi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Contoreggi's full profile

Already have an account?

  • Office

    Mercy Hospital of Baltimore
    345 St Paul Place
    Baltimore, MD 21202
    Phone+1 410-332-9177

Summary

  • Chief, Nuclear and Molecular Imaging and Therapeutics
    Mercy Hospital of Maryland, Baltimore

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Nuclear Medicine, 1991 - 1993
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1988
  • Johns Hopkins University/Bayview Medical Center
    Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1983 - 1985
  • Sinai Hospital of Baltimore
    Sinai Hospital of BaltimoreInternship, Internal Medicine, 1982 - 1983
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1982, MD
  • William & Mary
    William & MaryBachelor, Biology/Chemistry, Magna Cum Laude, 1974 - 1978

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1984 - 2026
  • PA State Medical License
    PA State Medical License 1992 - 1994
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

  • NIH Director's Award, Francis Collins MD, PhD NIH, 2014
  • Commendation Medal for Exemplary Service in Performance of Translational Research with University of Maryland School of Medicine USPHS, 2012
  • Clinical Director, Intramural Research Program, National Institute on Drug Abuse National Institutes of Health, 2002-2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Corticotropin releasing hormone and imaging, rethinking the stress axis  
    Contoreggi C, Nucl Med Biol, 1/1/2014
  • [76Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor  
    Jagoda EM, Lang L, Contoreggi C, McCullough K, Kim BM, Ma Y, Rice KC, Szajek LP, Eckelman WC, Kiesewetter DO, Synapse, 1/1/2011
  • Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotrophin-releasing hormone receptor antagonist  
    Horn TL, Harder JB, Johnson WD, Curry PT, Parchment RE, Morrissey RL, Mellick PW, Calis KA, Gold PW, Rice KC, Contoreggi C, Charney DS, Cizza G, Glaze ER, Tomaszewski ..., Toxicology, 4/9/2008
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Cocaine-Related Cues Elicit Craving and Activate Cortical Circuits Relevant to Episodic Memory.
    London ED, Grant S, Newlin D, Villemagne V, Phillips R, Liu X, Kimes AS, Contoreggi C, and Margolin A, Biol Psychiatry, 1/1/1996
  • Evaluation of an HTLV II risk population with an HTLV-I / HTLV-II combination immunoassay and an HTLV-I-II western immunoblot.
    Robertson E, Stephens J, Chan E, Motley C, Buytendrop M, Prillaman J, Coleman C, Garrett N, Welblan B, Contoreggi C., Hoffman W, and Phelps B, HIV; Sixth International Conference on Human Retrovirology, Absecon, NJ, 1/1/1994

Lectures

  • The management of incidental findings in functional imaging research. 
    Kona, HI - 1/1/2009
  • Bromocriptine Reduces Hyperphagia and Adiposity in (fa/fa) Zucker and Diet-Induced Obese Rats through Selective Changes in Dopamine (DA) D2 receptor (D2R) and DA Trans... 
    New Orleans, LA - 1/20/2007
  • PET imaging with 2-[18F]F-A-85380 showa increased densities of nicotinic receptors in heavy smokers compared to non-smokers. 
    Washington, DC - 1/1/2005
  • Join now to see all

Research History

  • Clinical/Research Fellow in Nuclear and Molecular ImagingFocused on Neuroreceptor Imaging w/positron emission tomography1990 - 1994

Professional Memberships

  • Endocrine Society
    Member
  • Society of Nuclear and Molecular Imaging
    Member

Other Languages

  • French